<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36997517</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology.</ArticleTitle><Pagination><StartPage>1783</StartPage><MedlinePgn>1783</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1783</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-37378-z</ELocationID><Abstract><AbstractText>Current methods for detecting infections either require a sample collected from an actively infected site, are limited in the number of agents they can query, and/or yield no information on the immune response. Here we present an approach that uses temporally coordinated changes in highly-multiplexed antibody measurements from longitudinal blood samples to monitor infection events at sub-species resolution across the human virome. In a longitudinally-sampled cohort of South African adolescents representing &gt;100 person-years, we identify &gt;650 events across 48 virus species and observe strong epidemic effects, including high-incidence waves of Aichivirus A and the D68 subtype of Enterovirus D earlier than their widespread circulation was appreciated. In separate cohorts of adults who were sampled at higher frequency using self-collected dried blood spots, we show that such events temporally correlate with symptoms and transient inflammatory biomarker elevations, and observe the responding antibodies to persist for periods ranging from ≤1 week to &gt;5 years. Our approach generates a rich view of viral/host dynamics, supporting novel studies in immunology and epidemiology.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Erin J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-4164-0771</Identifier><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henson</LastName><ForeName>Sierra N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-9246-4392</Identifier><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahee</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyle</LastName><ForeName>Annalee S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelbrektson</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Georgia A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mead</LastName><ForeName>Heather L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>N Leigh</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>SISCAPA Assay Technologies, Inc., Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razavi</LastName><ForeName>Morteza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>SISCAPA Assay Technologies, Inc., Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>SISCAPA Assay Technologies, Inc., Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladner</LastName><ForeName>Jason T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0001-7751-4366</Identifier><AffiliationInfo><Affiliation>The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scriba</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><Identifier Source="ORCID">0000-0002-0641-1359</Identifier><AffiliationInfo><Affiliation>South African Tuberculosis Vaccine Initiative and Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altin</LastName><ForeName>John A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-7587-7470</Identifier><AffiliationInfo><Affiliation>The Translational Genomics Research Institute (TGen), Flagstaff and Phoenix, AZ, USA. jaltin@tgen.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 AI152172</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083422" MajorTopicYN="N">Virome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36997517</ArticleId><ArticleId IdType="pmc">PMC10062260</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-37378-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-37378-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Woolhouse M, Scott F, Hudson Z, Howey R, Chase-Topping M. Human viruses: discovery and emergence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012;367:2864–2871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427559</ArticleId><ArticleId IdType="pubmed">22966141</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolhouse MEJ, Brierley L. Epidemiological characteristics of human-infective RNA viruses. Sci. Data. 2018;5:180017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5819479</ArticleId><ArticleId IdType="pubmed">29461515</ArticleId></ArticleIdList></Reference><Reference><Citation>Byington CL, et al. Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin. Infect. Dis. 2015;61:1217–1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4583580</ArticleId><ArticleId IdType="pubmed">26245665</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung NHL, Xu C, Ip DKM, Cowling BJ. Review article: The fraction of influenza virus infections that are asymptomatic: A systematic review and meta-analysis. Epidemiology. 2015;26:862–872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586318</ArticleId><ArticleId IdType="pubmed">26133025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann MF, Odermatt B, Hengartner H, Zinkernagel RM. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 1996;183:2259–2269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192556</ArticleId><ArticleId IdType="pubmed">8642335</ArticleId></ArticleIdList></Reference><Reference><Citation>Caliendo AM. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin. Infect. Dis. 2011;52:S326–S330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107927</ArticleId><ArticleId IdType="pubmed">21460291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko KKK, Chng KR, Nagarajan N. Metagenomics-enabled microbial surveillance. Nat. Microbiol. 2022;7:486–496.</Citation><ArticleIdList><ArticleId IdType="pubmed">35365786</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai G-H, Lin S-C, Hsu Y-H, Chen S-Y. The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications. Viruses. 2022;14:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8876576</ArticleId><ArticleId IdType="pubmed">35215871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami A, et al. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Clin. Microbiol. Infect. 2021;27:1762–1771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548624</ArticleId><ArticleId IdType="pubmed">34582980</ArticleId></ArticleIdList></Reference><Reference><Citation>Edridge AWD, et al. Seasonal coronavirus protective immunity is short-lasting. Nat. Med. 2020;26:1691–1693.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929268</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona SJ, et al. Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants. Mol. Cell. Proteom. 2015;14:1871–1884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4587317</ArticleId><ArticleId IdType="pubmed">25922409</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu GJ, et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 2015;348:aaa0698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4844011</ArticleId><ArticleId IdType="pubmed">26045439</ArticleId></ArticleIdList></Reference><Reference><Citation>Larman HB, et al. Autoantigen discovery with a synthetic human peptidome. Nat. Biotechnol. 2011;29:535–541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169279</ArticleId><ArticleId IdType="pubmed">21602805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladner JT, et al. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses. Cell Rep. Med. 2021;2:100189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816965</ArticleId><ArticleId IdType="pubmed">33495758</ArticleId></ArticleIdList></Reference><Reference><Citation>Elko, E. A. et al. COVID-19 vaccination elicits an evolving, cross- reactive antibody response to epitopes conserved with endemic coronavirus spike proteins. Cell Rep.10.1016/j.celrep.2022.111022 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188999</ArticleId><ArticleId IdType="pubmed">35753310</ArticleId></ArticleIdList></Reference><Reference><Citation>Henson SierraN, et al. PepSeq: a fully in-vitro platform for highly-multiplexed serology using customizable DNA-barcoded peptide libraries. Nat. Protoc. 2023;18:396–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10339795</ArticleId><ArticleId IdType="pubmed">36385198</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco DR, et al. Deconvoluting virome-wide antibody epitope reactivity profiles. eBioMedicine. 2022;75:103747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688874</ArticleId><ArticleId IdType="pubmed">34922324</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnard P, et al. Temporal virus serological profiling of kidney graft recipients using VirScan. Proc. Natl Acad. Sci. U. S. A. 2019;116:10899–10904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6561175</ArticleId><ArticleId IdType="pubmed">31085644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender Ignacio RA, et al. Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation. Blood. 2019;134:503–514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6688428</ArticleId><ArticleId IdType="pubmed">31186276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296–301.</Citation><ArticleIdList><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. U. S. A. 2005;102:15545–15550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahomed H, et al. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int. J. Tuberc. Lung Dis. 2011;15:331–336.</Citation><ArticleIdList><ArticleId IdType="pubmed">21333099</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirtcliff EA, Coe CL, Pollak SD. Early childhood stress is associated with elevated antibody levels to herpes simplex virus type 1. Proc. Natl Acad. Sci. U. S. A. 2009;106:2963–2967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634803</ArticleId><ArticleId IdType="pubmed">19188604</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen H, Klein SL. Sex Differences in Immunity to Viral Infections. Front. Immunol. 2021;12:720952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438138</ArticleId><ArticleId IdType="pubmed">34531867</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug RM, Etkind PR. Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology. 1973;56:334–348.</Citation><ArticleIdList><ArticleId IdType="pubmed">4795673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaki H, Sugiura T, Sugita S, Imagawa H, Kida H. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses. Vet. Microbiol. 2001;82:111–119.</Citation><ArticleIdList><ArticleId IdType="pubmed">11423202</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N, et al. Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis. MBio. 2019;10:e01903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692520</ArticleId><ArticleId IdType="pubmed">31409689</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson L, et al. Precision multiparameter tracking of inflammation on timescales of hours to years using serial dried blood spots. Bioanalysis. 2020;12:937–955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372997</ArticleId><ArticleId IdType="pubmed">32253915</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson NL, et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) J. Proteome Res. 2004;3:235–244.</Citation><ArticleIdList><ArticleId IdType="pubmed">15113099</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol. Infect. 1993;110:145–160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2271959</ArticleId><ArticleId IdType="pubmed">8432318</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkinen T, Järvinen A. The common cold. Lancet. 2003;361:51–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112468</ArticleId><ArticleId IdType="pubmed">12517470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokars JI, Olsen SJ, Reed C. Seasonal Incidence of Symptomatic Influenza in the United States. Clin. Infect. Dis. 2018;66:1511–1518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5934309</ArticleId><ArticleId IdType="pubmed">29206909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan KM, Monto AS, Longini IM., Jr. Estimates of the US health impact of influenza. Am. J. Public Health. 1993;83:1712–1716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1694912</ArticleId><ArticleId IdType="pubmed">8259800</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: a systematic review. Lancet Infect. Dis. 2016;16:e64–e75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, et al. Acute flaccid myelitis: A clinical review of US cases 2012–2015. Ann. Neurol. 2016;80:326–338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098271</ArticleId><ArticleId IdType="pubmed">27422805</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, et al. Seroepidemiology of enterovirus D68 infection in China. Emerg. Microbes Infect. 2017;6:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520479</ArticleId><ArticleId IdType="pubmed">28487560</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivadulla E, Romalde JL. A Comprehensive Review on Human Aichi Virus. Virol. Sin. 2020;35:501–516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223127</ArticleId><ArticleId IdType="pubmed">32342286</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh D-Y, et al. Molecular characterization of the first Aichi viruses isolated in Europe and in South America. Arch. Virol. 2006;151:1199–1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">16421634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora M. DNA Viruses (CMV, EBV, and the Herpesviruses) Semin. Respiratory Crit. Care Med. 2011;32:454–470.</Citation><ArticleIdList><ArticleId IdType="pubmed">21858750</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 2004;4:26–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">14720565</ArticleId></ArticleIdList></Reference><Reference><Citation>Forte E, Zhang Z, Thorp EB, Hummel M. Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response. Front. Cell. Infect. Microbiol. 2020;10:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136410</ArticleId><ArticleId IdType="pubmed">32296651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong H, et al. A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine. PLOS ONE. 2022;17:e0265870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9071131</ArticleId><ArticleId IdType="pubmed">35512030</ArticleId></ArticleIdList></Reference><Reference><Citation>Scriba TJ, et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 2017;13:e1006687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689825</ArticleId><ArticleId IdType="pubmed">29145483</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink, Z. W., Martinez, V., Altin, J. &amp; Ladner, J. T. PepSIRF: a flexible and comprehensive tool for the analysis of data from highly-multiplexed DNA-barcoded peptide assays. arXiv Preprint at 10.48550/arXiv.2007.05050 (2020).</Citation></Reference><Reference><Citation>Wu T, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Altin, J. &amp; Kelley, E. Data from ‘Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology’. Preprint at 10.17605/OSF.IO/6HT43 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10062260</ArticleId><ArticleId IdType="pubmed">36997517</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>